Improvement in glycaemic control and reduction in body weight over 52 weeks with dapagliflozin as add-on therapy to metformin plus sulphonylurea

被引：0
|
作者：
Matthaei, S. [1 ]
Bowering, K. [2 ]
Rohwedder, K. [3 ]
Grohl, A. [4 ]
Johnsson, E. [5 ]
机构：
[1] Diabet Zentrum Quakenbruck, Berlin, Germany
[2] Univ Alberta, Edmonton, AB, Canada
[3] AstraZeneca, Wedel, Germany
[4] Aptiv Solut, Cologne, Germany
[5] AstraZeneca, Molndal, Sweden
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
852
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [1] Improvement in Glycemic Control and Reduction in Body Weight over 52 Weeks with Dapagliflozin as Add-on Therapy to Metformin plus Sulfonylurea
    Matthaei, Stephan
    Bowering, Keith
    Rohwedder, Katja
    Grohl, Anke
    Johnsson, Eva
    DIABETES, 2014, 63 : A70 - A71
  • [2] Dapagliflozin improves glycaemic control and reduces body weight as add-on therapy to metformin plus sulphonylurea
    Matthaei, S.
    Rohwedder, K.
    Grohl, A.
    Johnsson, E.
    DIABETOLOGIA, 2013, 56 : S374 - S375
  • [3] Durability and tolerability of dapagliflozin over 52 weeks as add-on to metformin and sulphonylurea in type 2 diabetes
    Matthaei, S.
    Bowering, K.
    Rohwedder, K.
    Sugg, J.
    Parikh, S.
    Johnsson, E.
    DIABETES OBESITY & METABOLISM, 2015, 17 (11): : 1075 - 1084
  • [4] Efficacy and safety of triple therapy with dapagliflozin add-on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetes
    Mathieu, C.
    Herrera Marmolejo, M.
    Gonzalez Gonzalez, J. G.
    Hansen, L.
    Chen, H.
    Johnsson, E.
    Garcia-Sanchez, R.
    Iqbal, N.
    DIABETES OBESITY & METABOLISM, 2016, 18 (11): : 1134 - 1137
  • [5] Liraglutide as add-on to metformin in type 2 diabetes: significant improvement in glycaemic control with a reduction in body weight compared with glimepiride
    Nauck, M
    Hompesch, N
    Filipczak, R
    Le, TTD
    Nielsen, L
    Zdravkovic, M
    Gumprecht, J
    DIABETOLOGIA, 2004, 47 : A281 - A281
  • [6] A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea
    Moses, R. G.
    Kalra, S.
    Brook, D.
    Sockler, J.
    Monyak, J.
    Visvanathan, J.
    Montanaro, M.
    Fisher, S. A.
    DIABETES OBESITY & METABOLISM, 2014, 16 (05): : 443 - 450
  • [7] Significantly better glycaemic control/weight reduction with human GLP-1 analogue liraglutide, than with insulin glargine: all as add-on to metformin plus sulphonylurea in type 2 diabetes
    Russell-Jones, D.
    Vaag, A.
    Schmitz, O.
    Sethi, B.
    Lalic, N. M.
    Antic, S.
    Zdravkovic, M.
    Ravn, G. M.
    Simo, R.
    DIABETOLOGIA, 2008, 51 : S68 - S68
  • [8] Sitagliptin Add-On to Metformin plus Sulphonylurea Combination Therapy: The Efficacy of Triple Therapy on Glycemic Control in Type 2 Diabetes
    Sargin, Mehmet
    Tekin, Sakin
    Can, Ozgur
    Kisioglu, Savas Volkan
    Tekin, Buket Vatansever
    Orbay, Ekrem
    Tekce, Mustafa
    Aliustaoglu, Mehmet
    DIABETES, 2013, 62 : A669 - A670
  • [9] Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data
    Del Prato, S.
    Nauck, M.
    Duran-Garcia, S.
    Maffei, L.
    Rohwedder, K.
    Theuerkauf, A.
    Parikh, S.
    DIABETES OBESITY & METABOLISM, 2015, 17 (06): : 581 - 590
  • [10] Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial
    Matthaei, Stephan
    Bowering, Keith
    Rohwedder, Katja
    Grohl, Anke
    Parikh, Shamik
    DIABETES CARE, 2015, 38 (03) : 365 - 372
12345